Association between anthropometry and lifestyle factors and risk of B-cell lymphoma: An exposome-wide analysis.


Journal

International journal of cancer
ISSN: 1097-0215
Titre abrégé: Int J Cancer
Pays: United States
ID NLM: 0042124

Informations de publication

Date de publication:
01 05 2021
Historique:
revised: 28 09 2020
received: 07 05 2020
accepted: 13 10 2020
pubmed: 1 11 2020
medline: 8 9 2021
entrez: 31 10 2020
Statut: ppublish

Résumé

To better understand the role of individual and lifestyle factors in human disease, an exposome-wide association study was performed to investigate within a single-study anthropometry measures and lifestyle factors previously associated with B-cell lymphoma (BCL). Within the European Prospective Investigation into Cancer and nutrition study, 2402 incident BCL cases were diagnosed from 475 426 participants that were followed-up on average 14 years. Standard and penalized Cox regression models as well as principal component analysis (PCA) were used to evaluate 84 exposures in relation to BCL risk. Standard and penalized Cox regression models showed a positive association between anthropometric measures and BCL and multiple myeloma/plasma cell neoplasm (MM). The penalized Cox models additionally showed the association between several exposures from categories of physical activity, smoking status, medical history, socioeconomic position, diet and BCL and/or the subtypes. PCAs confirmed the individual associations but also showed additional observations. The PC5 including anthropometry, was positively associated with BCL, diffuse large B-cell lymphoma (DLBCL) and MM. There was a significant positive association between consumption of sugar and confectionary (PC11) and follicular lymphoma risk, and an inverse association between fish and shellfish and Vitamin D (PC15) and DLBCL risk. The PC1 including features of the Mediterranean diet and diet with lower inflammatory score showed an inverse association with BCL risk, while the PC7, including dairy, was positively associated with BCL and DLBCL risk. Physical activity (PC10) was positively associated with DLBCL risk among women. This study provided informative insights on the etiology of BCL.

Identifiants

pubmed: 33128820
doi: 10.1002/ijc.33369
pmc: PMC8048490
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2115-2128

Subventions

Organisme : Medical Research Council
ID : 1000143 (to EPIC-Norfolk)
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0401527
Pays : United Kingdom
Organisme : Cancer Research UK
ID : 14136
Pays : United Kingdom
Organisme : Cancer Research UK
ID : C570/A16491
Pays : United Kingdom
Organisme : Cancer Research UK
ID : 14136 (to EPIC-Norfolk)
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/N003284/1
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 205212/Z/16/Z
Pays : United Kingdom
Organisme : Cancer Research UK
ID : C570/A11692
Pays : United Kingdom
Organisme : Medical Research Council
ID : G1000143
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/M012190/1 (to EPIC-Oxford)
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom

Informations de copyright

© 2020 The Authors. International Journal of Cancer published by John Wiley & Sons Ltd on behalf of Union for International Cancer Control.

Références

Cancer Epidemiol Biomarkers Prev. 2003 Aug;12(8):796-802
pubmed: 12917212
Ann Oncol. 2019 Apr 1;30(4):528-541
pubmed: 30753270
Lancet Diabetes Endocrinol. 2016 May;4(5):457-67
pubmed: 26827112
Haematologica. 2008 Nov;93(11):1666-77
pubmed: 18835833
J Clin Oncol. 2010 Sep 20;28(27):4191-8
pubmed: 20713849
Am J Clin Nutr. 2017 Aug;106(2):650-656
pubmed: 28659300
Int J Cancer. 2020 May 15;146(10):2680-2693
pubmed: 31319002
Int J Cancer. 2021 May 1;148(9):2115-2128
pubmed: 33128820
Blood. 2010 Nov 18;116(20):e90-8
pubmed: 20699439
Leuk Lymphoma. 2006 Dec;47(12):2477-87
pubmed: 17169793
Int J Cancer. 2019 Jul 1;145(1):122-131
pubmed: 30588620
Lancet Oncol. 2011 Aug;12(8):785-94
pubmed: 21782509
Public Health Nutr. 2002 Dec;5(6B):1163-76
pubmed: 12639225
Med Sci Sports Exerc. 2000 Sep;32(9 Suppl):S498-504
pubmed: 10993420
J Cancer Res Clin Oncol. 2010 Jan;136(1):71-7
pubmed: 19582474
Int J Cancer. 2018 Aug 1;143(3):486-495
pubmed: 29460427
Medicine (Baltimore). 2018 Mar;97(12):e0172
pubmed: 29561429
Sci Rep. 2017 Aug 29;7(1):9757
pubmed: 28851931
PLoS One. 2008;3(11):e3639
pubmed: 18982064
Public Health Nutr. 2002 Aug;5(4):561-5
pubmed: 12186665
Int J Epidemiol. 1997;26 Suppl 1:S1-5
pubmed: 9126528
J Natl Cancer Inst Monogr. 2014 Aug;2014(48):130-44
pubmed: 25174034
Leuk Lymphoma. 2012 Oct;53(10):1853-4
pubmed: 22462617
Public Health Nutr. 2002 Dec;5(6B):1147-62
pubmed: 12639224
Int J Cancer. 2019 Jul 15;145(2):347-359
pubmed: 30614529
Int J Epidemiol. 1997;26 Suppl 1:S181-9
pubmed: 9126546
Cancer Causes Control. 2013 Jan;24(1):125-34
pubmed: 23160945
Eur J Clin Nutr. 2007 Sep;61(9):1037-56
pubmed: 17375121
Atherosclerosis. 2018 Feb;269:172-177
pubmed: 29366990
Eur J Cancer. 2010 Sep;46(14):2593-604
pubmed: 20843488
Environ Mol Mutagen. 2013 Aug;54(7):542-57
pubmed: 23918146
Am J Epidemiol. 2010 Jul 1;172(1):58-69
pubmed: 20562184
Future Microbiol. 2009 Nov;4(9):1151-65
pubmed: 19895218
J Intern Med. 2017 Nov;282(5):360-370
pubmed: 28875507
Cancer Causes Control. 2007 Jun;18(5):537-49
pubmed: 17443415
J Natl Cancer Inst. 1999 Oct 20;91(20):1751-8
pubmed: 10528026
Int J Cancer. 2013 Jun 15;132(12):2918-27
pubmed: 23180513
Obes Facts. 2013;6(4):369-79
pubmed: 23970146
Br J Pharmacol. 2019 Jun;176(12):1818-1828
pubmed: 29952002
Public Health Nutr. 2002 Dec;5(6B):1113-24
pubmed: 12639222
Occup Environ Med. 2011 Jan;68(1):77-81
pubmed: 20884795
Int J Epidemiol. 1997;26 Suppl 1:S6-14
pubmed: 9126529
Cancer Epidemiol Biomarkers Prev. 2005 Feb;14(2):512-20
pubmed: 15734980
Int J Epidemiol. 2013 Dec;42(6):1795-810
pubmed: 24345851
Eur J Cancer Prev. 2004 Aug;13(4):337-43
pubmed: 15554562
Public Health Nutr. 2003 Jun;6(4):407-13
pubmed: 12795830
Cancer Causes Control. 2017 Jul;28(7):791-799
pubmed: 28503716
Cancer Epidemiol Biomarkers Prev. 2007 Mar;16(3):392-5
pubmed: 17337642
Public Health Nutr. 2004 Sep;7(6):723-7
pubmed: 15369609
Int J Cancer. 2006 Jun 1;118(11):2871-6
pubmed: 16385566
Nutr Cancer. 2017 Feb-Mar;69(2):221-228
pubmed: 28094569
Eur J Cancer. 2011 Mar;47(5):748-60
pubmed: 21159506
Public Health Nutr. 2014 Aug;17(8):1689-96
pubmed: 23941862
PLoS One. 2010 May 20;5(5):e10746
pubmed: 20505766
Am J Clin Nutr. 2018 Apr 1;107(4):607-616
pubmed: 29635497
Eur J Nutr. 2020 Mar;59(2):813-823
pubmed: 30903361
Leuk Lymphoma. 2012 Oct;53(10):1911-9
pubmed: 22397720
J Nutr Biochem. 2008 Jun;19(6):347-61
pubmed: 18499033
Environ Health Perspect. 2016 Dec;124(12):1848-1856
pubmed: 27219331
J Stat Softw. 2011 Mar;39(5):1-13
pubmed: 27065756
Am J Epidemiol. 2008 May 1;167(9):1081-9
pubmed: 18321867
Am J Epidemiol. 2004 Mar 1;159(5):454-66
pubmed: 14977641
Nutrients. 2014 Jan 03;6(1):231-48
pubmed: 24394536

Auteurs

Fatemeh Saberi Hosnijeh (F)

Division of Environmental Epidemiology, Institute for Risk Assessment Sciences, Utrecht University, Utrecht, The Netherlands.
Department of Immunology, Laboratory Medical Immunology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.

Delphine Casabonne (D)

Unit of Infections and Cancer, Cancer Epidemiology Research Programme, IDIBELL, Catalan Institute of Oncology, Badalona, Spain.
Centro de Investigación Biomédica en Red: Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.

Alexandra Nieters (A)

Institute for Immunodeficiency, Faculty of Medicine and Medical Center, University of Freiburg, Freiburg, Germany.

Marta Solans (M)

Centro de Investigación Biomédica en Red: Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
Research Group on Statistics, Econometrics and Health (GRECS), University of Girona, Girona, Spain.

Sabine Naudin (S)

Nutritional Methodology and Biostatistics Group, International Agency for Research on Cancer, World Health Organization, Lyon, France.

Pietro Ferrari (P)

Nutritional Methodology and Biostatistics Group, International Agency for Research on Cancer, World Health Organization, Lyon, France.

James D Mckay (JD)

Section of Genetics, International Agency for Research on Cancer, Lyon, France.

Yolanda Benavente (Y)

Unit of Infections and Cancer, Cancer Epidemiology Research Programme, IDIBELL, Catalan Institute of Oncology, Badalona, Spain.
Centro de Investigación Biomédica en Red: Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.

Elisabete Weiderpass (E)

International Agency for Research on Cancer, World Health Organization, Lyon, France.

Heinz Freisling (H)

Nutritional Methodology and Biostatistics Group, International Agency for Research on Cancer, World Health Organization, Lyon, France.

Gianluca Severi (G)

Université Paris-Saclay, UVSQ, CESP U1018 INSERM, Villejuif, France.
Gustave Roussy, Villejuif, France.
Department of Statistics, Computer Science, Applications "G. Parenti", University of Florence, Florence, Italy.

Marie-Christine Boutron Ruault (MC)

Université Paris-Saclay, UVSQ, CESP U1018 INSERM, Villejuif, France.
Gustave Roussy, Villejuif, France.

Caroline Besson (C)

Université Paris-Saclay, UVSQ, CESP U1018 INSERM, Villejuif, France.
UFR sciences de la santé, Université Versailles Saint Quentin en Yvelines, Université Paris-Saclay, Communaute Paris-Saclay (Carol), Saint-Aubin, France.
Versailles Hospital, Unit of Hematology-Oncology, Le Chesnay, France.

Claudia Agnoli (C)

Epidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

Giovanna Masala (G)

Cancer Risk Factors and Life-Style Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network-ISPRO, Florence, Italy.

Carlotta Sacerdote (C)

Unit of Cancer Epidemiology, Città della Salute e della Scienza University-Hospital and Center for Cancer Prevention (CPO), Turin, Italy.

Rosario Tumino (R)

Cancer Registry and Histopathology Department, Azienda Sanitaria Provinciale, Ragusa, Italy.

José María Huerta (JM)

Department of Epidemiology, Murcia Regional Health Council, IMIB-Arrixaca, Murcia, Spain.
CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.

Pilar Amiano (P)

Public Health Division of Gipuzkoa, BioDonostia Research Institute, San Sebastian; CIBER Epidemiología y Salud Pública, Madrid, Spain.

Miguel Rodriguez-Barranco (M)

Escuela Andaluza de Salud Pública (EASP), Granada, Spain.
Instituto de Investigación Biosanitaria ibs.GRANADA, Granada, Spain.
Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.

Catalina Bonet (C)

Unit of Nutrition and Cancer, Catalan Institute of Oncology-ICO, Nutrition and Cancer Group, Bellvitge Biomedical Research Institute-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.

Aurelio Barricarte (A)

Centro de Investigación Biomédica en Red: Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
Navarra Public Health Institute, Pamplona, Spain.
Navarra Institute for Health Research (IdiSNA), Pamplona, Spain.

Sofia Christakoudi (S)

Department of Epidemiology and Biostatistics, Imperial College London, London, UK.
MRC Centre for Transplantation, King's College London, London, UK.

Anika Knuppel (A)

Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.

Bas Bueno-de-Mesquita (B)

Department for Determinants of Chronic Diseases, National Institute for Public Health and the Environment (RIVM), The Netherlands.
Department of Gastroenterology and Hepatology, University Medical Centre, Utrecht, The Netherlands.

Matthias B Schulze (MB)

Department of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany.
Institute of Nutritional Sciences, University of Potsdam, Nuthetal, Germany.

Rudolf Kaaks (R)

Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Federico Canzian (F)

Research Group Genomic Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Florentin Späth (F)

Department of Radiation Sciences, Oncology and Cancer center, Department of Hematology, Umeå University, Umeå, Sweden.

Mats Jerkeman (M)

Department of Oncology, Lund University, Lund, Sweden.
Department of Oncology, Skane University Hospital, Lund, Sweden.

Charlotta Rylander (C)

Department of Public Health, University of Copenhagen, Copenhagen, Denmark.

Anne Tjønneland (A)

Department of Public Health, University of Copenhagen, Copenhagen, Denmark.
Danish Cancer Society Research Center, Copenhagen, Denmark.

Anja Olsen (A)

Danish Cancer Society Research Center, Copenhagen, Denmark.

Kristin Benjaminsen Borch (KB)

Department of Community Medicine, UiT, The Arctic University of Norway, Tromsø, Norway.

Roel Vermeulen (R)

Division of Environmental Epidemiology, Institute for Risk Assessment Sciences, Utrecht University, Utrecht, The Netherlands.
Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands.
MRC-PHE Centre for Environment and Health, Department of Epidemiology and Biostatistics, Imperial College London, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH